Drug Profile
Research programme: CMV-based HPV vaccines - Vir Biotechnology
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Oregon Health & Science University; TomegaVax
- Developer Oregon Health & Science University; Vir Biotechnology
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Human papillomavirus infections
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Human-papillomavirus-infections in USA (Parenteral)
- 09 Aug 2016 Early research in Human papillomavirus infections in USA (Parenteral)